+ All Categories
Home > Documents > Metabolic bone disease

Metabolic bone disease

Date post: 24-Feb-2016
Category:
Upload: mikaia
View: 53 times
Download: 0 times
Share this document with a friend
Description:
Metabolic bone disease. Dr santosh kumar Assistant professor Medical unit 2. Definition . The term “metabolic bone disease” denotes those Conditions producing diffusely decreased bone density And diminished bone strength. . O steoporosis . Essential of diagnosis. - PowerPoint PPT Presentation
Popular Tags:
29
Metabolic bone disease Dr santosh kumar Assistant professor Medical unit 2
Transcript
Page 1: Metabolic bone disease

Metabolic bone disease

Dr santosh kumarAssistant professorMedical unit 2

Page 2: Metabolic bone disease

Definition The term “metabolic bone disease” denotes thoseConditions producing diffusely decreased bone densityAnd diminished bone strength.

Page 3: Metabolic bone disease

Osteoporosis

Page 4: Metabolic bone disease
Page 5: Metabolic bone disease

Essential of diagnosis Asymptomatic to severe backache from vertebral fractures. Spontaneous fractures often discovered incidentally on radiography; loss of height. Serum PTH, calcium, phosphorus, and alkaline phos- phatase usually normal. Serum 25-hydroxyvitamin D levels often low as a comorbid condition. Demineralization, especially of spine, hip, pelvis, and wrist

Page 6: Metabolic bone disease

Definition It is defined as low bone mass and micro-architecturaldestructions of Bone tissue leading fragility and fracture of bone.Bone is normally mineralized but decrease in quantity ,quality and Structural Integrity.

Page 7: Metabolic bone disease

Peak bone mass and bone loss are regulated by genetic(80%) and environmental factor (20%),genetic like (ESR1)oestrogen receptor

gene,(LRP5)lipoprotein related receptor gene In normal individual 20-40years bone

formation is increased but fall after that. After menopause is an accelerated phase of

bone loss.

pathophysiology

Page 8: Metabolic bone disease

Post menopausal osteoporosis Osteoporosis in men Steroid induced osteoporosis Pregnancy associated osteoporosis Other causes

variety

Page 9: Metabolic bone disease

Hypogonadism Hyperthyroidism Hyperparathyroidism Cushings syndrome Etc

Endocrine disease

Page 10: Metabolic bone disease

Inflammatory bowel disease Ankylosing spondylitis RA Etc

Inflammatory disease

Page 11: Metabolic bone disease

Malabsorption syndrome Chronic liver disease Others causes

Gasterointestinal disease

Page 12: Metabolic bone disease

Corticosteroids Thyroxine over –replacement Gonadotrophin-releasing hormone agonist Sedative Anticonvulsant drugs Alcohal excess Heparin others

drugs

Page 13: Metabolic bone disease

Myeloma Homocystinuria Anorexia nervousa High trained athletes HIV infection Immobilisation Poor diet /low birth weight

miscellaneous

Page 14: Metabolic bone disease

Asymtomatic until fracture occurs. Osteoporotic spinal fracture present back pain or gradual onset of height loss and kyphosis

with chronic pain. in hip fracture affected leg shortened and

externally rotated. Some time on bony pain in old age or

menupause Incidental osteopenia in xrays performed foe

other reasons.

Sign and symptoms

Page 15: Metabolic bone disease
Page 16: Metabolic bone disease

InvestigationsX rays of bone related limbRoutine profile of bloodSerum calcium level Alkaline phosphatase levelBone density like radiographs, DXA sccaning

Page 17: Metabolic bone disease
Page 18: Metabolic bone disease
Page 19: Metabolic bone disease
Page 20: Metabolic bone disease
Page 21: Metabolic bone disease
Page 22: Metabolic bone disease

Management of osteoporosis• Assess risk factors• If present, proceed to DXA (may not be necessary In all patients with fragility fractures).• Exclude secondary causes in patients with osteoporosis

Page 23: Metabolic bone disease
Page 24: Metabolic bone disease

In patients with previous fragility fracture And those aged over 65 years with BMD T

Score < -2.5 measured by DXA

• Offer lifestyle advice (e.g. exercise, diet, smoking cessation)• Offer treatment: First-line option alendronate or risedronate Also-raloxifene in woman with vertebral osteoporosis -Teriparatide in woman with very severe osteoporosis, or if intolerant to other therapies Give calcium and vitamin D supplements where appropriate

Page 25: Metabolic bone disease
Page 26: Metabolic bone disease

In younger patients with BMD T score < -2.5(measured by DXA, hip + spine)

• Assess need for treatment based on age and other independent risk factors• Offer lifestyle advice• Offer treatment as above, if appropriate

Page 27: Metabolic bone disease

In frail older individuals• Offer lifestyle advice• Fall risk assessment and advice where appropriate• Give calcium and vitamin D supplements• Hip protectors for individuals in nursing homes

Page 28: Metabolic bone disease
Page 29: Metabolic bone disease

Thanks


Recommended